Vericel (VCEL) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $41.02, +1.91% vs the prior close of $40.25.
- Volume 601.20K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VCEL rises 1.9% to $41.02. Closed at $41.02, +1.91% vs the prior close of $40.25. Day range $40.26–$41.60, opened at $40.77.
VCEL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — VCEL rises 1.9% to $41.02
- Closed at $41.02, +1.91% vs the prior close of $40.25. Day range $40.26–$41.60, opened at $40.77.
- Volume was 601.20K shares, 1.2x its 50-day average of 504.45K.
- Price is -0.2% vs its 50-day average ($41.12) and +6.7% vs its 200-day average ($38.44).
- 52-week range $28.95–$49.32; today's close sits at 59% of that range, 16.8% below the 52-week high.
Oct 14, 2026 — VCEL ends flat (-0.1%) to $40.25
- Closed at $40.25, -0.12% vs the prior close of $40.30. Day range $39.60–$40.31, opened at $39.90.
- Volume was 384.50K shares, 0.8x its 50-day average of 505.58K.
- Price is -2.3% vs its 50-day average ($41.21) and +4.8% vs its 200-day average ($38.42).
- 52-week range $28.95–$49.32; today's close sits at 55% of that range, 18.4% below the 52-week high.
Oct 13, 2026 — VCEL dips 0.8% to $40.30
- Closed at $40.30, -0.79% vs the prior close of $40.62. Day range $39.99–$40.77, opened at $40.62.
- Volume was 511.70K shares, 1.0x its 50-day average of 505.30K.
- Price is -2.5% vs its 50-day average ($41.33) and +4.9% vs its 200-day average ($38.41).
- 52-week range $28.95–$49.32; today's close sits at 56% of that range, 18.3% below the 52-week high.
Oct 12, 2026 — VCEL rises 1.3% to $40.62
- Closed at $40.62, +1.30% vs the prior close of $40.10. Day range $39.00–$40.81, opened at $40.30.
- Volume was 432.90K shares, 0.9x its 50-day average of 507.07K.
- Price is -2.0% vs its 50-day average ($41.45) and +5.8% vs its 200-day average ($38.39).
- 52-week range $28.95–$49.32; today's close sits at 57% of that range, 17.6% below the 52-week high.
Oct 9, 2026 — VCEL ends flat (+0.1%) to $40.10
- Closed at $40.10, +0.12% vs the prior close of $40.05. Day range $39.78–$41.13, opened at $39.83.
- Volume was 506.90K shares, 1.0x its 50-day average of 516.67K.
- Price is -3.5% vs its 50-day average ($41.55) and +4.5% vs its 200-day average ($38.38).
- 52-week range $28.95–$49.32; today's close sits at 55% of that range, 18.7% below the 52-week high.
Oct 8, 2026 — VCEL dips 1.7% to $40.05
- Closed at $40.05, -1.69% vs the prior close of $40.74. Day range $39.81–$40.94, opened at $40.53.
- Volume was 749.10K shares, 1.5x its 50-day average of 511.80K.
- Price is -4.0% vs its 50-day average ($41.70) and +4.4% vs its 200-day average ($38.36).
- 52-week range $28.95–$49.32; today's close sits at 54% of that range, 18.8% below the 52-week high.
Oct 7, 2026 — VCEL rises 1.7% to $40.74
- Closed at $40.74, +1.72% vs the prior close of $40.05. Day range $39.50–$41.40, opened at $39.67.
- Volume was 647.00K shares, 1.3x its 50-day average of 507.53K.
- Price is -2.6% vs its 50-day average ($41.83) and +6.3% vs its 200-day average ($38.34).
- 52-week range $28.95–$49.32; today's close sits at 58% of that range, 17.4% below the 52-week high.
Oct 6, 2026 — VCEL dips 2.5% to $40.05
- Closed at $40.05, -2.48% vs the prior close of $41.07. Day range $39.65–$41.45, opened at $41.38.
- Volume was 669.00K shares, 1.3x its 50-day average of 502.05K.
- Price is -4.5% vs its 50-day average ($41.95) and +4.5% vs its 200-day average ($38.32).
- 52-week range $28.95–$49.32; today's close sits at 54% of that range, 18.8% below the 52-week high.
Oct 5, 2026 — VCEL rises 2.3% to $41.07, a 1-month high
- Closed at $41.07, +2.29% vs the prior close of $40.15. Day range $39.93–$41.17, opened at $40.13.
- Volume was 648.60K shares, 1.3x its 50-day average of 496.28K.
- Price is -2.3% vs its 50-day average ($42.06) and +7.2% vs its 200-day average ($38.30).
- 52-week range $28.95–$49.32; today's close sits at 59% of that range, 16.7% below the 52-week high.
Oct 2, 2026 — VCEL rises 1.8% to $40.15
- Closed at $40.15, +1.80% vs the prior close of $39.44. Day range $39.37–$40.40, opened at $40.01.
- Volume was 479.20K shares, 1.0x its 50-day average of 501.00K.
- Price is -4.7% vs its 50-day average ($42.14) and +4.9% vs its 200-day average ($38.27).
- 52-week range $28.95–$49.32; today's close sits at 55% of that range, 18.6% below the 52-week high.
VCEL latest news & SEC filings
Every SEC filing by or about VCEL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mclaughlin Kevin F sold 7,000 shares at $44.53 (≈$311.71K) on Aug 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Halpin Michael sold 10,000 shares at $46.84 (≈$468.40K) on Aug 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 3, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Siegal Jonathan sold 2,500 shares at $48.90 (≈$122.25K) on Jul 30, 2026
- Siegal Jonathan sold 1,500 shares at $48.90 (≈$73.35K) on Jul 30, 2026
- Siegal Jonathan sold 500 shares at $48.90 (≈$24.45K) on Jul 30, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 30, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $77.46M (prior year $63.24M) (+22.5% vs Jun 30, 2025)
- Net income: $2.21M (prior year -$553.00K) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.04 (prior year -$0.01) (swung to profit vs Jun 30, 2025)
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade VCEL
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Jan 13, 2026. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.41% (largest 3.6%).
- Liquidity: about 555.19K shares (≈$22.77M) trade per day on average.
- 52-week position: $41.02 vs a range of $28.95–$49.32 (59% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Kevin F Mclaughlin sold 7,000 shares on Aug 12, 2026.
- Latest filings: 10-Q Jul 30, 2026; 8-K Jul 30, 2026; 8-K May 18, 2026.
- Share count: 51.21M shares outstanding (Jul 24, 2026), +1.5% vs a year earlier.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
VCEL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 40.77 | 41.60 | 40.26 | 41.02 | 601.20K |
| Oct 14, 2026 | 39.90 | 40.31 | 39.60 | 40.25 | 384.50K |
| Oct 13, 2026 | 40.62 | 40.77 | 39.99 | 40.30 | 511.70K |
| Oct 12, 2026 | 40.30 | 40.81 | 39.00 | 40.62 | 432.90K |
| Oct 9, 2026 | 39.83 | 41.13 | 39.78 | 40.10 | 506.90K |
| Oct 8, 2026 | 40.53 | 40.94 | 39.81 | 40.05 | 749.10K |
| Oct 7, 2026 | 39.67 | 41.40 | 39.50 | 40.74 | 647.00K |
| Oct 6, 2026 | 41.38 | 41.45 | 39.65 | 40.05 | 669.00K |
| Oct 5, 2026 | 40.13 | 41.17 | 39.93 | 41.07 | 648.60K |
| Oct 2, 2026 | 40.01 | 40.40 | 39.37 | 40.15 | 479.20K |
| Oct 1, 2026 | 40.27 | 40.72 | 39.29 | 39.44 | 497.30K |
| Sep 30, 2026 | 40.79 | 41.08 | 39.82 | 40.14 | 585.40K |
| Sep 29, 2026 | 40.27 | 40.83 | 39.93 | 40.61 | 526.90K |
| Sep 28, 2026 | 39.78 | 41.05 | 39.65 | 40.24 | 643.10K |
| Sep 25, 2026 | 39.30 | 39.80 | 38.74 | 39.71 | 359.30K |
| Sep 24, 2026 | 38.86 | 39.40 | 38.39 | 39.30 | 352.00K |
| Sep 23, 2026 | 39.95 | 40.10 | 38.21 | 38.79 | 434.00K |
| Sep 22, 2026 | 40.00 | 40.42 | 39.55 | 40.22 | 547.00K |
| Sep 21, 2026 | 40.08 | 40.29 | 39.05 | 39.55 | 402.20K |
| Sep 18, 2026 | 39.80 | 40.21 | 39.57 | 40.02 | 1.13M |
About Vericel
Vericel (VCEL) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in BURLINGTON, MA. State of incorporation: MI. Fiscal year ends December 31. SEC CIK 887359.
VCEL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Dominick Colangelo | President and CEO | Feb 26, 2026 |
| Heidi Hagen | Director | May 1, 2026 |
| Kevin F Mclaughlin | Director | Aug 14, 2026 |
| Alan L Rubino | Director | May 1, 2026 |
| Lisa Wright | Director | May 1, 2026 |
| Paul K Wotton | Director | May 13, 2026 |
| Robert L Md Zerbe | Director | May 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Dominick Colangelo | President and CEO | Feb 26, 2026 |
| Sean C. Flynn | Chief Legal Officer | Jun 30, 2026 |
| Michael Halpin | Chief Operating Officer | Aug 5, 2026 |
| Jonathan Mark Hopper | Chief Medical Officer | Jun 30, 2026 |
| Karen Mahoney | Chief Human Resources Officer | Dec 12, 2025 |
| Joseph Anthony Jr Mara | Chief Financial Officer | Jun 30, 2026 |
| Jonathan Siegal | Principal Accounting Officer | Jul 31, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 12, 2026 | Kevin F Mclaughlin | Sale | 7,000 | $44.53 |
| Aug 3, 2026 | Michael Halpin | Sale | 10,000 | $46.84 |
| Jul 30, 2026 | Jonathan Siegal | Sale | 2,500 | $48.90 |
| Jul 30, 2026 | Jonathan Siegal | Sale | 1,500 | $48.90 |
| Jul 30, 2026 | Jonathan Siegal | Sale | 500 | $48.90 |
| Jun 26, 2026 | Sean C. Flynn | Sale | 15,000 | $45.64 |
| Jun 26, 2026 | Joseph Anthony Jr Mara | Sale | 5,000 | $44.75 |
| Jun 26, 2026 | Jonathan Mark Hopper | Sale | 5,000 | $45.00 |
| Jun 26, 2026 | Jonathan Mark Hopper | Sale | 5,000 | $45.00 |
| Jun 26, 2026 | Jonathan Siegal | Sale | 2,500 | $44.90 |
| Jun 26, 2026 | Jonathan Siegal | Sale | 232 | $44.90 |
| Jun 18, 2026 | Sean C. Flynn | Sale | 15,000 | $40.21 |
| Jun 18, 2026 | Michael Halpin | Sale | 10,000 | $40.24 |
| Jun 2, 2026 | Jonathan Mark Hopper | Sale | 4,375 | $35.00 |
| May 13, 2026 | Kevin F Mclaughlin | Sale | 3,500 | $32.83 |
VCEL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $276.26M | $16.52M | 0.32 | $51.91M |
| Dec 31, 2024 | $237.22M | $10.36M | 0.20 | $58.16M |
| Dec 31, 2023 | $197.52M | $-3.18M | -0.07 | $35.31M |
| Dec 31, 2022 | $163.70M | $-16.71M | -0.35 | $17.69M |
| Dec 31, 2021 | $153.07M | $-7.47M | -0.16 | $29.04M |
Latest balance sheet: total assets $502.87M, total liabilities $132.82M, cash $125.36M (as of Jun 30, 2026).
VCEL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $47.61 |
| May 7, 2026 | 8-K Item 2.02 (results) | $35.13 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $37.68 |
| Jan 13, 2026 | 8-K Item 2.02 (results) | $37.05 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $38.75 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $34.94 |
| May 8, 2025 | 8-K Item 2.02 (results) | $41.87 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $49.62 |
| Jan 14, 2025 | 8-K Item 2.02 (results) | $58.67 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $50.03 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on VCEL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.